These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 3052390)
1. Actinomycosis affecting the fallopian tube and ovary: report of 3 cases, with special reference to 2 cases following IUD application. Hsu CT; Roan CH; Rai SY; Jong HL; Chen TY; Lin YN; Lan CC Asia Oceania J Obstet Gynaecol; 1988 Sep; 14(3):275-84. PubMed ID: 3052390 [TBL] [Abstract][Full Text] [Related]
2. Pelvic actinomycosis and usage of intrauterine contraceptive devices. Kelly J; Aaron J Yale J Biol Med; 1982; 55(5-6):453-61. PubMed ID: 7183022 [TBL] [Abstract][Full Text] [Related]
4. Actinomyces israelii in the female genital tract: a review. Evans DT Genitourin Med; 1993 Feb; 69(1):54-9. PubMed ID: 8444484 [TBL] [Abstract][Full Text] [Related]
5. Pelvic actinomycosis in association with an intrauterine device. Garland SM; Rawling D Aust N Z J Obstet Gynaecol; 1993 Feb; 33(1):96-8. PubMed ID: 8498956 [TBL] [Abstract][Full Text] [Related]
6. Microbiological and histological findings in the fallopian tubes of women using various contraceptive methods. Collins JA; Gillett PG; Perlin IA; Embil JA; Zayid I; Richards G; Kirk ME Contraception; 1984 Nov; 30(5):457-66. PubMed ID: 6394206 [TBL] [Abstract][Full Text] [Related]
7. Pelvic actinomycosis associated with use of intrauterine device: a new challenge for the surgeon. Doberneck RC Am Surg; 1982 Jan; 48(1):25-7. PubMed ID: 7065552 [TBL] [Abstract][Full Text] [Related]
8. Systemic Actinomyces infection. A potential complication of intrauterine contraceptive devices. de la Monte SM; Gupta PK; White CL JAMA; 1982 Oct; 248(15):1876-7. PubMed ID: 7120609 [TBL] [Abstract][Full Text] [Related]
9. Pelvic actinomycosis in women using intrauterine contraceptive devices. Hager WD; Majmudar B Am J Obstet Gynecol; 1979 Jan; 133(1):60-3. PubMed ID: 760536 [TBL] [Abstract][Full Text] [Related]
10. Chest wall actinomycosis in association with the use of an intra-uterine device. McBride WJ; Hill DR; Gordon DL Aust N Z J Surg; 1995 Feb; 65(2):141-3. PubMed ID: 7857230 [TBL] [Abstract][Full Text] [Related]
11. Actinomyces naeslundii as an agent of pelvic actinomycosis in the presence of an intrauterine device. Bonnez W; Lattimer G; Mohanraj NA; Johnson TH J Clin Microbiol; 1985 Feb; 21(2):273-5. PubMed ID: 3973000 [TBL] [Abstract][Full Text] [Related]
16. IUD and salpingitis: a prospective study of pathomorphological changes in the oviducts in IUD-users. Beerthuizen RJ; Van Wijck JA; Eskes TK; Vermeulen AH; Vooijs GP Eur J Obstet Gynecol Reprod Biol; 1982 Feb; 13(1):31-41. PubMed ID: 7060816 [TBL] [Abstract][Full Text] [Related]
18. Pelvic actinomycosis associated with intrauterine contraceptive devices--a review of 6 cases. Hsu SP; Wang KG; Yang YC; Lan CC Zhonghua Yi Xue Za Zhi (Taipei); 1990 Nov; 46(5):289-92. PubMed ID: 2178067 [TBL] [Abstract][Full Text] [Related]
20. Residues of pelvic inflammatory disease in intrauterine device users: a result of the intrauterine device or Chlamydia trachomatis infection? Guderian AM; Trobough GE Am J Obstet Gynecol; 1986 Mar; 154(3):497-503. PubMed ID: 3513579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]